Hahr A - Search Results

1

Addressing secondary prevention of osteoporosis in fracture care: follow-up to "own the bone".

Edwards BJ, Koval K, Bunta AD, Genuario K, Hahr A, Andruszyn L, Williams M. Edwards BJ, et al. Among authors: hahr a. J Bone Joint Surg Am. 2011 Aug 3;93(15):e87. doi: 10.2106/JBJS.I.00540. J Bone Joint Surg Am. 2011. PMID: 21915530

2

Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.

Edwards BJ, Bunta AD, Lane J, Odvina C, Rao DS, Raisch DW, McKoy JM, Omar I, Belknap SM, Garg V, Hahr AJ, Samaras AT, Fisher MJ, West DP, Langman CB, Stern PH. Edwards BJ, et al. Among authors: hahr aj. J Bone Joint Surg Am. 2013 Feb 20;95(4):297-307. doi: 10.2106/JBJS.K.01181. J Bone Joint Surg Am. 2013. PMID: 23426763 Free PMC article. Review.

3

Development of an electronic medical record based intervention to improve medical care of osteoporosis.

Edwards BJ, Bunta AD, Anderson J, Bobb A, Hahr A, O'Leary KJ, Agulnek A, Andruszyn L, Cameron KA, May M, Kazmers NH, Dillon N, Baker DW, Williams MV. Edwards BJ, et al. Among authors: hahr a. Osteoporos Int. 2012 Oct;23(10):2489-98. doi: 10.1007/s00198-011-1866-9. Epub 2012 Jan 25. Osteoporos Int. 2012. PMID: 22273834

4

Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project.

Edwards BJ, Usmani S, Raisch DW, McKoy JM, Samaras AT, Belknap SM, Trifilio SM, Hahr A, Bunta AD, Abu-Alfa A, Langman CB, Rosen ST, West DP. Edwards BJ, et al. Among authors: hahr a. J Oncol Pract. 2013 Mar;9(2):101-6. doi: 10.1200/JOP.2011.000486. J Oncol Pract. 2013. PMID: 23814519 Free PMC article.

5

Elevated incidence of fractures in solid-organ transplant recipients on glucocorticoid-sparing immunosuppressive regimens.

Edwards BJ, Desai A, Tsai J, Du H, Edwards GR, Bunta AD, Hahr A, Abecassis M, Sprague S. Edwards BJ, et al. Among authors: hahr a. J Osteoporos. 2011;2011:591793. doi: 10.4061/2011/591793. Epub 2011 Sep 12. J Osteoporos. 2011. PMID: 21922049 Free PMC article.

6

Primary hyperaldosteronism: challenges in subtype classification.

Layden BT, Hahr AJ, Elaraj DM. Layden BT, et al. Among authors: hahr aj. BMC Res Notes. 2012 Oct 30;5:602. doi: 10.1186/1756-0500-5-602. BMC Res Notes. 2012. PMID: 23110780 Free PMC article.

7

Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.

Hahr AJ, Molitch ME. Hahr AJ, et al. Am J Ther. 2008 Nov-Dec;15(6):543-50. doi: 10.1097/MJT.0b013e31815aeb79. Am J Ther. 2008. PMID: 19127139 Review.

8

Electronic Health Record-Based Strategy to Promote Medication Adherence Among Patients With Diabetes: Longitudinal Observational Study.

Bailey SC, Wallia A, Wright S, Wismer GA, Infanzon AC, Curtis LM, Brokenshire SA, Chung AE, Reuland DS, Hahr AJ, Hornbuckle K, Lockwood K, Hall L, Wolf MS. Bailey SC, et al. Among authors: hahr aj. J Med Internet Res. 2019 Oct 21;21(10):e13499. doi: 10.2196/13499. J Med Internet Res. 2019. PMID: 31638592 Free PMC article.

9

Diabetes, cardiovascular risk and nephropathy.

Hahr AJ, Molitch ME. Hahr AJ, et al. Cardiol Clin. 2010 Aug;28(3):467-75. doi: 10.1016/j.ccl.2010.04.006. Epub 2010 Jun 1. Cardiol Clin. 2010. PMID: 20621251 Review.

10

Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.

Hahr AJ, Molitch ME. Hahr AJ, et al. Dis Mon. 2010 Mar;56(3):148-62. doi: 10.1016/j.disamonth.2009.12.009. Dis Mon. 2010. PMID: 20189500 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page